Results research

Concall Intelligence

Follow the Sept 2026 quarter results season by comparing what companies reported with what management said next. Search official call evidence, measurable guidance, changing outlook, operating risks, and prior commitments without treating commentary as a trading recommendation.

Open reported results

Matching calls

After selected filters

Transcript verified

Official transcript summaries on this page

Preliminary briefs

Presentation evidence, clearly labelled

Processing

Transcript filed or call source found

Tracked companies

Watchlist or portfolio matches

Management evidence

Generated 22 Oct, 9:09 am IST · click a summary to inspect source-linked evidence for this results quarter.

Clear filters

Company	Call and sources	Reported result	Management outlook	Evidence-led conclusion
ARSSBL Anand Rathi Share and Stock Brokers Limited Financial Services · Small	Sept 2026 21 Oct 2026 Transcript verified Transcript PPT Recording	Excellent 77/100	Optimistic outlook No comparable prior call Guidance maintained	Anand Rathi Share and Stock Brokers Limited delivered a robust financial performance in Q2 FY27, reporting strong year-on-year growth in revenue and PAT supported by expansion in the Margin Trading Facility (MTF) and distribution businesses, despite a turbulent secondary market. Evidence summary ready
SHOPERSTOP Shoppers Stop Limited Consumer · Small	Sep 2026 21 Oct 2026 Transcript verified Transcript PPT	Bad 22/100	Optimistic outlook No comparable prior call Guidance raised	Shoppers Stop delivered modest top‑line growth and a turnaround to profitability, driven by strong festive demand, premiumisation initiatives and new store openings, while highlighting ongoing work on inventory and working‑capital optimisation. Evidence summary ready
SUDARSCHEM Sudarshan Chemical Industries Limited Chemicals · Micro	Sep 2026 10 Oct 2026 Transcript verified Transcript PPT Recording	Result pending No matching current-quarter result row	Optimistic outlook No comparable prior call Guidance maintained	Sudarshan Chemical delivered a robust Q1 FY2027 performance following the Clariant-Heubach integration, achieving consolidated revenue of over Rs.2,600 Crores and solid EBITDA expansion. Despite geopolitical headwinds and supply chain friction, management remains focused on value capture, cost reduction, and completing IT integration while maintaining a cautious wait-and-watch approach on guidance. Evidence summary ready

Method: Deterministic quarterly-result score from reported growth, margin direction and operating leverage. Derived only from extracted, source-linked management evidence. Pending is shown when evidence is insufficient. Measurable claims are separated from general commentary and retain outcome status when later evidence exists. Transcript-verified summaries rank above preliminary presentation briefs and source-only call evidence. Preliminary briefs are replaced automatically when an official transcript is processed. Management outlook and colours describe extracted commentary evidence; they are not buy or sell labels.